VWING VASCULAR NEEDLE GUIDE 00146

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2016-03-24 for VWING VASCULAR NEEDLE GUIDE 00146 manufactured by Vital Access Corp..

Event Text Entries

[41033514] Still implanted - removal scheduled.
Patient Sequence No: 1, Text Type: N, H10


[41033515] Patient (b)(6) had a scab over their arterial access site, which showed pus once removed. A blood culture was negative, but a skin culture at the site showed klebsiella pneumoniae. Patient received antibiotics (ancef) but refused to receive a central venous catheter during healing. Cannulations of the patient's fistula are continuing outide of the vwing sites. Vwing devices are scheduled to be removed.
Patient Sequence No: 1, Text Type: D, B5


[41432381] Patient kw had a scab over their arterial access site, which showed pus once removed. A blood culture was (b)(6), but a skin culture at the site showed klebsiella pneumoniae. Patient received antibiotics (ancef) but refused to receive a central venous catheter during healing. Cannulations of the patient's fistula are continuing outside of the vwing sites. Initially, the company was informed that the vwing devices were scheduled to be removed. Upon seeing the patient, the implanting surgeon was able to further diagnose the patient. While the patient did have a cannulation-related infection, this infection was determined to be separate from the vwing devices. The patient was diagnosed with an infected hematoma. The vwing devices were both left in place in the patient while the hematoma healed. The company has been informed that the patient is now being cannulated successfully through their vwing devices again. No vwing-related serious adverse event occurred. Devices not removed - not infected.
Patient Sequence No: 1, Text Type: N, H10


[41432382] Patient kw had a scab over their arterial access site, which showed pus once removed. A blood culture was (b)(6), but a skin culture at the site showed klebsiella pneumoniae. Patient received antibiotics (ancef) but refused to receive a central venous catheter during healing. Cannulations of the patient's fistula are continuing outside of the vwing sites. Initially, the company was informed that the vwing devices were scheduled to be removed. Upon seeing the patient, the implanting surgeon was able to further diagnose the patient. While the patient did have a cannulation-related infection, this infection was determined to be separate from the vwing devices. The patient was diagnosed with an infected hematoma. The vwing devices were both left in place in the patient while the hematoma healed. The company has been informed that the patient is now being cannulated successfully through their vwing devices again. No vwing-related serious adverse event occurred.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3009273792-2015-00002
MDR Report Key5522440
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2016-03-24
Date of Report2016-03-30
Date of Event2015-11-18
Date Mfgr Received2015-11-30
Device Manufacturer Date2015-03-15
Date Added to Maude2016-03-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMARK CRAWFORD
Manufacturer Street448 E. WINCHESTER ST. SUITE 250
Manufacturer CitySALT LAKE CITY UT 84107
Manufacturer CountryUS
Manufacturer Postal84107
Manufacturer Phone8014339390
Manufacturer G1VITAL ACCESS CORP.
Manufacturer Street448 E. WINCHESTER ST. SUITE 250
Manufacturer CitySALT LAKE CITY UT 84107
Manufacturer CountryUS
Manufacturer Postal Code84107
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameVWING VASCULAR NEEDLE GUIDE
Generic NameVWING
Product CodePFH
Date Received2016-03-24
Model Number00146
Lot Number15-0032
OperatorPHYSICIAN
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerVITAL ACCESS CORP.
Manufacturer Address448 E. WINCHESTER ST. SUITE 250 SALT LAKE CITY UT 84107 US 84107


Patients

Patient NumberTreatmentOutcomeDate
10 2016-03-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.